The board of directors, management and advisors of Protagenic Therapeutics consist of individuals with substantial industry, scientific and clinical experience who bring a wealth of pharmaceutical product discovery and development as well as financial expertise to the company.

Board of Directors

› Garo H. Armen, PhD,
   Chairman of the Board of the Directors

› Haro Hartounian, PhD,
   Director

› Khalil Barrage,
   Director

Management

› Robert A. Ziroyan, PhD,
   Interim President & Chief Operating Officer

› David A. Lovejoy, PhD,
   Chief Scientific Officer

› Dalia Barsyte PhD,
   Director of Scientific Affairs

› Lifang Song, MSc,
   Senior Scientist

Scientific and Clinical Advisory Board

› David A. Lovejoy, PhD,
   Chief Scientific Officer

› Sidney H. Kennedy, MD, FRCP (C),
   Member of Scientific & Clinical Advisory Board

› Jean-Michel Aubry,
   Member of Scientific & Clinical Advisory Board

ˆ back to top